Welcome to the July issue of Pathway, a monthly magazine designed for anyone interested in their health and wellbeing and in the integral role that pathology plays in the diagnosis, treatment and management of diseases.
This month’s issue of Pathway looks at the following:
Could some drugs which have previously been developed to treat other viral infections also be effective against SARS-CoV-2, the virus that causes COVID-19?
Developing and maintaining quality of COVID-19 testing through proficiency testing
Earlier this year, RCPAQAP responded to requests from the Department of Health and from reference laboratories nationally, to produce an urgent proficiency testing program (PTP) for SARS-CoV-2.
During COVID-19, some units temporarily suspended organ transplantation, such as kidney, while other life-saving transplants such as heart, liver or lung continued cautiously.
Whilst people living with diabetes are not at increased risk of being infected with COVID-19, evidence suggests that they are at higher risk of more severe COVID-19.
